Octagon Capital Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-199,417	Closed	-$16.6M	–	42
2022 Q4	$16.6M	Sell	199,417 -43,983	-18%	-$3.65M	2.58%	11
2022 Q3	$19.3M	Hold	243,400	–	–	3.33%	8
2022 Q2	$18.1M	Buy	243,400 +187,600	+336%	+$13.9M	4.82%	7
2022 Q1	$5.02M	Buy	+55,800	New	+$5.02M	1.08%	20